BCL2L12 and melanoma: As expected, this list included well documented frequent oncogenic drivers of melanoma, including hotspot mutations in BRAF, NRAS, RAC1, PPP6C, TRRAP, MAP3K5 and BCL2L12 [5, 17, 27-29].